Login to Your Account

U.S. Patent Disclosures

Tuesday, January 18, 2011
Immunitor USA Inc., of College Park, Md., has received U.S. Patent No. 7,838,006, titled "Viral vaccine composition, process and methods of use," relating to claims covering the composition of matter for Immunitor's lead product, V5.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription